During the past decade, Northwest Neurospecialists PLLC conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 7 clinical trials were completed, i.e. on average, 700% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwest Neurospecialists PLLC" #1 sponsor was "Genzyme, a Sanofi Company" with 3 trials, followed by "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored, "Eisai Inc." with 2 trials sponsored, "Epix Pharmaceuticals, Inc." with 2 trials sponsored and "Impax Laboratories, LLC" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Neurospecialists PLLC" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "Bayer" with 3 trials as a collaborator, "Eisai Inc." with 1 trials as a collaborator, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 1 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Neurospecialists PLLC" are "Alzheimer's Disease" (9 trials), "Multiple Sclerosis" (4 trials), "Multiple Sclerosis, Relapsing-Remitting" (4 trials), "Parkinson's Disease" (2 trials) and "Relapsing Remitting Multiple Sclerosis" (2 trials). Many other conditions were trialed in "Northwest Neurospecialists PLLC" in a lesser frequency.

Most popular intervention types in "Northwest Neurospecialists PLLC" are "Drug" (17 trials), "Biological" (5 trials), "Other" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials), "Interferon beta-1a" (2 trials) and "PRX-03140" (2 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Neurospecialists PLLC" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Northwest Neurospecialists PLLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Northwest Neurospecialists PLLC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Neurospecialists PLLC, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".